Tumor Necrosis Factor Gene Polymorphisms in Tunisian Patients With Behçet’s Disease
Authors:
- Hanene ChelbiHCHanene Chelbi
- Mohamed Habib HoumanMHMohamed Habib Houman
- Jihene LachebJLJihene Lacheb
- Kamel HamzaouiKHKamel Hamzaoui
- 1 March 2007
- journal article
- Published by Elsevier in Human Immunology
- Vol. 68 (3) , 201-205
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Manifestations thoraciques des maladies de Behçet et de TakayasuRevue des Maladies Respiratoires, 2005
- Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's diseaseClinical and Experimental Dermatology, 2005
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximabRheumatology, 2001
- Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case reportGastroenterology, 2001
- Behçet’s diseasePostgraduate Medical Journal, 2000
- Behçet’s Syndrome1999
- Role of γδ T lymphocytes in the development of Behc¸et's diseaseClinical and Experimental Immunology, 1997
- Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)Clinical and Experimental Immunology, 1996
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993